Division of Gastroenterology, University of Health Sciences, Diyabakır Gazi Yasargil Education and Research Hospital, Diyarbakır, Turkey.
Ministry of Health Silvan State Hospital Internal Medicine Clinic, Diyarbakır, Turkey.
Saudi J Gastroenterol. 2022 Nov-Dec;28(6):434-440. doi: 10.4103/sjg.sjg_114_22.
To investigage the thiol and disulphide levels in Helicobacter pylori-positive patients with non-ulcer dyspepsia and investigate the change in these levels with eradication therapy.
This is a prospective observational study. A total of 320 patients diagnosed with dyspepsia according to Rome IV criteria were included in the study. First, blood samples were drawn from patients to determine their serum thiol and disulphide levels. Endoscopic biopsy was performed on all patients and the biopsy specimens obtained were examined pathologically. Patients positive for H. pylori were administered eradication therapy. Blood samples were drawn from these patients for the second time, and their serum thiol and disulphide levels were measured. The thiol-disulfide levels of the patients who were successful in H. pylori eradication treatment, with those who were not, were compared before and after the treatment.
The mean plasma disulphide level decreased significantly from 14.0 ± 6.6 to 10.9 ± 5.9 μmol/L in H. pylori-positive patients that responded to the H. pylori eradication treatment (P = 0.033). On the other hand, there was an insignificant increase in the mean serum thiol level (341.4 ± 30.5 vs. 342.6 ± 29.8 μmol/L; P = 0.273) and an insignificant decrease in the mean serum disulphide level (15.2 ± 2.5 vs. 14.8 ± 2.3 μmol/L; P = 0.163) in H. pylori-positive patients that did not respond to the H. pylori eradication treatment.
The inflammation caused by H. pylori shifted the thiol-disulphide equilibrium in the cell redox system towards the direction of disulphide. The study findings suggest that the restoration of the said hemostatic balance with eradication therapy relieved the organism from oxidative stress.
研究幽门螺杆菌阳性的非溃疡性消化不良患者的巯基和二硫键水平,并研究这些水平在根除治疗后的变化。
这是一项前瞻性观察性研究。共纳入 320 例根据罗马 IV 标准诊断为消化不良的患者。首先,从患者中抽取血样,以确定其血清巯基和二硫键水平。对所有患者进行内镜活检,检查活检标本的病理。幽门螺杆菌阳性的患者给予根除治疗。从这些患者中抽取第二次血样,测量其血清巯基和二硫键水平。比较治疗成功和治疗失败的幽门螺杆菌阳性患者治疗前后的巯基-二硫键水平。
对幽门螺杆菌根除治疗有反应的幽门螺杆菌阳性患者的血浆二硫键水平从 14.0 ± 6.6 显著降低至 10.9 ± 5.9 μmol/L(P = 0.033)。另一方面,血清巯基水平的平均升高无统计学意义(341.4 ± 30.5 比 342.6 ± 29.8 μmol/L;P = 0.273),血清二硫键水平的平均降低也无统计学意义(15.2 ± 2.5 比 14.8 ± 2.3 μmol/L;P = 0.163)。
幽门螺杆菌引起的炎症使细胞氧化还原系统中的巯基-二硫键平衡向二硫键方向移动。研究结果表明,根除治疗恢复了这种止血平衡,使机体摆脱了氧化应激。